1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction

R L Singhal1, N Prajda, Y A Yeh

  • 1Laboratory for Experimental Oncology, Indiana University School of Medicine, Indianapolis 16202-5200.

Cancer Research
|November 1, 1994
PubMed

Insights

PIP kinase (1-phosphatidylinositol 4-phosphate 5-kinase) activity is significantly elevated in rapidly growing rat hepatomas and highly proliferative tissues. This suggests a crucial role for PIP kinase in cell proliferation and cancer development.

Area of Science:

  • Biochemistry
  • Enzymology
  • Cancer Research

Background:

  • PIP kinase (1-phosphatidylinositol 4-phosphate 5-kinase) is a key enzyme in the biosynthesis of inositol trisphosphate and diacylglycerol.
  • Understanding PIP kinase activity is crucial for elucidating cellular signaling pathways and their dysregulation in cancer.

Purpose of the Study:

  • To investigate PIP kinase activity in various rat tissues and transplantable hepatomas.
  • To correlate PIP kinase activity with cell proliferation rates and cancer progression.

Main Methods:

  • Enzyme activity assays using a standard isotopic method.
  • Determination of kinetic parameters (Km) for PIP, ATP, and Mg2+.
  • Analysis of enzyme decay rates following cycloheximide treatment.

Main Results:

  • PIP kinase activity was significantly higher (3.3- to 45-fold) in rat hepatomas compared to normal liver, correlating with growth rate.
  • Highly proliferative rat organs (thymus, bone marrow, spleen, testes) exhibited 4.3- to 6.3-fold higher PIP kinase activity than liver.
  • PIP kinase demonstrated a rapid decay rate (t1/2 = 0.12 h) in cycloheximide-treated animals, indicating a short half-life.

Conclusions:

  • PIP kinase activity is closely linked to cell proliferation and transformation.
  • Elevated PIP kinase levels in hepatomas and proliferative tissues suggest its role in cancer development.
  • The findings imply a heightened capacity for signal transduction in cancer cells due to increased PIP kinase activity.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...